Balloon Angioplasty Catheters Gain Quicker Path To Market Under FDA Rule
This article was originally published in The Gray Sheet
Executive Summary
Standard balloon-tipped angioplasty catheters can enter the market through the 510(k) clearance process, rather than the PMA route, beginning next month
You may also be interested in...
FDA Device Center Gears Up For Product Reclassification Push
FDA is hiring additional staff and channeling user fee funds toward device reclassification efforts now that it has committed itself to more rapidly addressing the subset of Class III devices that still enters the market via 510(k)
Balloon Catheters Might Finally Be Moved Down To 510(k) Status, FDA Signals
FDA says most standard balloon angioplasty catheters should be allowed on the market with 510(k)s rather than the current PMA standard
PTCA Catheter Downclassification Carries Unresolved Safety Issues - Panel
Postmarket surveillance requirements should be part of any decision to downclassify percutaneous transluminal coronary angioplasty (PTCA) balloon catheters from Class III to Class II, according to FDA's Circulatory System Devices Panel.